We are live on ! Find out more
DILH

Dai-ichi Life Holdings Portfolio holdings

AUM $104M
1-Year Est. Return 4.63%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+4.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.34B
AUM Growth
-$209M
Cap. Flow
-$214M
Cap. Flow %
-6.41%
Top 10 Hldgs %
32.59%
Holding
690
New
33
Increased
88
Reduced
406
Closed
31

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$9.14M
2
AAPL icon
Apple
AAPL
+$8.67M
3
QCOM icon
Qualcomm
QCOM
+$7.97M
4
SRE icon
Sempra
SRE
+$6.7M
5
WFC icon
Wells Fargo
WFC
+$6.6M

Sector Composition

Rank Sector Weight
1 Financials 30.16%
2 Healthcare 12.48%
3 Technology 10.88%
4 Consumer Staples 8.24%
5 Consumer Discretionary 6.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
26
Visa
V
$691B
$19.3M 0.58%
286,744
-20,153
-7% -$1.37M
KO icon
27
Coca-Cola
KO
$372B
$18.3M 0.55%
467,590
-38,990
-8% -$1.59M
ORCL icon
28
Oracle
ORCL
$427B
$18.3M 0.55%
455,100
-43,225
-9% -$1.87M
MO icon
29
Altria Group
MO
$114B
$18.3M 0.55%
374,711
-5,985
-2% -$303K
CMCSA icon
30
Comcast
CMCSA
$88B
$18.1M 0.54%
602,628
-53,628
-8% -$1.57M
CVS icon
31
CVS Health
CVS
$133B
$17.7M 0.53%
168,347
-14,015
-8% -$1.43M
AGN
32
DELISTED
Allergan plc
AGN
$17.6M 0.53%
57,931
-4,623
-7% -$1.38M
CSCO icon
33
Cisco
CSCO
$477B
$17.4M 0.52%
633,746
-57,900
-8% -$1.66M
AMGN icon
34
Amgen
AMGN
$209B
$16M 0.48%
104,061
-9,789
-9% -$1.57M
CELG
35
DELISTED
Celgene Corp
CELG
$15.7M 0.47%
135,835
-18,369
-12% -$2.1M
INTC icon
36
Intel
INTC
$508B
$15.6M 0.47%
513,730
-68,482
-12% -$2.21M
IBM icon
37
IBM
IBM
$219B
$15.6M 0.47%
100,461
-4,012
-4% -$645K
MDT icon
38
Medtronic
MDT
$110B
$15.5M 0.46%
209,702
-28,143
-12% -$2.15M
BIIB icon
39
Biogen
BIIB
$30.6B
$15.5M 0.46%
38,405
-4,254
-10% -$1.71M
BMY icon
40
Bristol-Myers Squibb
BMY
$135B
$15M 0.45%
225,987
-21,197
-9% -$1.4M
PM icon
41
Philip Morris
PM
$290B
$15M 0.45%
187,035
-15,047
-7% -$1.24M
NKE icon
42
Nike
NKE
$61.8B
$14.8M 0.44%
274,478
-9,984
-4% -$511K
UNH icon
43
UnitedHealth
UNH
$373B
$14.7M 0.44%
120,572
-33,820
-22% -$4M
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.11T
$14.6M 0.44%
107,523
-44,786
-29% -$6.39M
ABBV icon
45
AbbVie
ABBV
$429B
$14.4M 0.43%
213,623
-16,889
-7% -$1.1M
MA icon
46
Mastercard
MA
$501B
$14.2M 0.42%
151,655
-14,661
-9% -$1.35M
TUR icon
47
iShares MSCI Turkey ETF
TUR
$214M
$13.9M 0.41%
307,362
+23,000
+8% +$1.08M
SBUX icon
48
Starbucks
SBUX
$120B
$13.5M 0.4%
251,839
+11,869
+5% +$602K
GIS icon
49
General Mills
GIS
$19.4B
$13.1M 0.39%
234,489
+6,947
+3% +$389K
MMM icon
50
3M
MMM
$92.9B
$12.9M 0.38%
99,712
-29,591
-23% -$3.97M

Similar funds

Dai-ichi Life Holdings's Q2 2015 Portfolio in Review

As of Q2 2015, Dai-ichi Life Holdings held 690 positions worth $3.34B, down 5.9% from $3.55B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Dai-ichi Life Holdings withdrew a net $214M in Q2 2015, closing 31 positions and reducing 406 holdings. Its most notable exit was LORILLARD INC COM STK, an estimated $9.14M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Dai-ichi Life Holdings opened a new position in Infinera Corporation Common Stock worth $2.37M.

  • Dai-ichi Life Holdings's largest Q2 2015 buy was Infinera Corporation Common Stock: 113,054 shares worth $2.37M.
  • Dai-ichi Life Holdings added most to iShares MSCI Brazil ETF in Q2 2015, an estimated $8.23M increase.
  • Dai-ichi Life Holdings's biggest Q2 2015 reduction was Apple, cutting an estimated $8.67M.
  • Dai-ichi Life Holdings fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $9.14M.
  • Dai-ichi Life Holdings's ten largest holdings make up 33% of its $3.34B portfolio in Q2 2015.
  • Dai-ichi Life Holdings opened 33 new positions and closed 31 in Q2 2015.
  • Dai-ichi Life Holdings's portfolio value fell 5.9% quarter-over-quarter to $3.34B.

Based on Dai-ichi Life Holdings's 13F filing for Q2 2015, filed 14 Aug 2015.